{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T17:30:01Z","timestamp":1695490201246},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T00:00:00Z","timestamp":1376956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00277-013-1864-4","type":"journal-article","created":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T10:38:26Z","timestamp":1376908706000},"page":"243-247","source":"Crossref","is-referenced-by-count":11,"title":["Association of polymorphisms in TRAIL1 and TRAILR1 genes with susceptibility to lymphomas"],"prefix":"10.1007","volume":"93","author":[{"given":"Beatriz","family":"Heredia-Galvez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ruiz-Cosano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Torres-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Espa\u00f1ol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Morales-Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"P\u00e9rez-Ceballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Gonz\u00e1lez-Conejero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Guti\u00e9rrez-C\u00edvicos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"P\u00e9rez-Guillermo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Conesa-Zamora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,20]]},"reference":[{"key":"1864_CR1","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1158\/1055-9965.EPI-06-0053","volume":"15","author":"B Frank","year":"2006","unstructured":"Frank B, Shanmugam KS, Beckmann L, Hemminki K, Brenner H, Hoffmeister M, Chang-Claude J, Burwinkel B (2006) Death receptor 4 variants and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 15:2002\u20132005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1864_CR2","first-page":"1157","volume":"63","author":"A Hazra","year":"2003","unstructured":"Hazra A, Chamberlain RM, Grossman HB, Zhu Y, Spitz MR, Wu X (2003) Death receptor 4 and bladder cancer risk. Cancer Res 63:1157\u20131159","journal-title":"Cancer Res"},{"key":"1864_CR3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/pros.20682","volume":"68","author":"T Langsenlehner","year":"2008","unstructured":"Langsenlehner T, Langsenlehner U, Renner W, Kapp KS, Krippl P, Hofmann G, Clar H, Pummer K, Mayer R (2008) The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases. Prostate 68:264\u2013268","journal-title":"Prostate"},{"key":"1864_CR4","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1016\/j.ejca.2009.06.023","volume":"45","author":"B Chen","year":"2009","unstructured":"Chen B, Liu S, Wang XLXW, Li Y, Zhao WH, Wu JQ (2009) TRAIL-R1 polymorphisms and cancer susceptibility: an evidence-based meta-analysis. Eur J Cancer 45:2598\u20132605","journal-title":"Eur J Cancer"},{"key":"1864_CR5","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/ijc.21502","volume":"118","author":"S Wolf","year":"2006","unstructured":"Wolf S, Mertens D, Pscherer A, Schroeter P, Winkler D, Gr\u00f6ne HJ, Hofele C, Hemminki K, Kumar R, Steineck G, D\u00f6hner H, Stilgenbauer S, Lichter P (2006) Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer. Int J Cancer 118:1831\u20131835","journal-title":"Int J Cancer"},{"key":"1864_CR6","first-page":"1322","volume":"89","author":"V Fernandez","year":"2004","unstructured":"Fernandez V, Jares P, Bea S, Salaverria I, Guino E, de Sanjos\u00e9 S, Colomer D, Ott G, Montserrat E, Campo E (2004) Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms. Haematologica 89:1322\u20131331","journal-title":"Haematologica"},{"key":"1864_CR7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.onc.1204103","volume":"20","author":"SH Lee","year":"2001","unstructured":"Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY, Lee JH, Han SY, Park JY, Oh RR, Kang CS, Kim KM, Jang JJ, Nam SW, Lee JY, Yoo NJ (2001) Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin\u2019s lymphoma. Oncogene 20:399\u2013403","journal-title":"Oncogene"},{"key":"1864_CR8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10549-010-0900-5","volume":"126","author":"R Pal","year":"2011","unstructured":"Pal R, Gochhait S, Chattopadhyay S, Gupta P, Prakash N, Agarwal G, Chaturvedi A, Husain N, Husain SA, Bamezai RN (2011) Functional implication of TRAIL \u2212716 C\/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor. Breast Cancer Res Treat 126:333\u2013343","journal-title":"Breast Cancer Res Treat"},{"key":"1864_CR9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/mc.20814","volume":"51","author":"J Ruiz-Cosano","year":"2012","unstructured":"Ruiz-Cosano J, Conesa-Zamora P, Gonz\u00e1lez-Conejero R, P\u00e9rez-Ceballos E, Mart\u00ednez-Franc\u00e9s A, Vicente V, P\u00e9rez-Guillermo M (2012) Role of GSTT1 and M1 null genotypes as risk factors for B-cell lymphoma: influence of geographical factors and occupational exposure. Mol Carcinog 51:508\u2013513","journal-title":"Mol Carcinog"},{"key":"1864_CR10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jbspin.2012.02.003","volume":"79","author":"MJ Morales-Lara","year":"2012","unstructured":"Morales-Lara MJ, Ca\u00f1ete JD, Torres-Moreno D, Hern\u00e1ndez MV, Pedrero F, Celis R, Garc\u00eda-Sim\u00f3n MS, Conesa-Zamora P (2012) Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis. Joint Bone Spine 79:591\u2013596","journal-title":"Joint Bone Spine"},{"key":"1864_CR11","doi-asserted-by":"crossref","unstructured":"Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, He L, Shi Y (2009) A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis. Cell Res 19:519\u201323. http:\/\/analysis2.bio-x.cn\/myAnalysis.php . Accessed 12 Jan 2013","DOI":"10.1038\/cr.2009.33"},{"key":"1864_CR12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ng0497supp-417","volume":"15","author":"F Mitelman","year":"1997","unstructured":"Mitelman F, Mertens F, Johansson B (1997) A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15:417\u2013474","journal-title":"Nat Genet"},{"key":"1864_CR13","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1182\/blood.V87.12.5269.bloodjournal87125269","volume":"87","author":"O Monni","year":"1996","unstructured":"Monni O, Joensuu H, Franssila K, Knuutila S (1996) DNA copy number changes in diffuse large B-cell lymphoma\u2014comparative genomic hybridization study. Blood 87:5269\u20135278","journal-title":"Blood"},{"key":"1864_CR14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2141.2009.07790.x","volume":"146","author":"XS Liang","year":"2009","unstructured":"Liang XS, Caporaso N, McMaster ML, Ng D, Landgren O, Yeager M, Chanock S, Goldin LR (2009) Common genetic variants in candidate genes and risk of familial lymphoid malignancies. Br J Haematol 146:418\u2013423","journal-title":"Br J Haematol"},{"key":"1864_CR15","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.2010.33.3252","volume":"29","author":"H Nogai","year":"2011","unstructured":"Nogai H, D\u00f6rken B, Lenz G (2011) Pathogenesis of non-Hodgkin\u2019s lymphoma. J Clin Oncol 29:1803\u20131811","journal-title":"J Clin Oncol"},{"key":"1864_CR16","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1158\/1078-0432.CCR-07-0680","volume":"13","author":"S Maddipatla","year":"2007","unstructured":"Maddipatla S, Hernandez-Ilizaliturri FJ, Knight J, Czuczman MS (2007) Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20. Clin Cancer Res 13:4556\u20134564","journal-title":"Clin Cancer Res"},{"key":"1864_CR17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cbpa.2010.07.002","volume":"14","author":"T Kodadek","year":"2010","unstructured":"Kodadek T (2010) Development of antibody surrogates for the treatment of cancers and autoimmune disease. Curr Opin Chem Biol 14:721\u2013727","journal-title":"Curr Opin Chem Biol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1864-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1864-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1864-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T04:57:18Z","timestamp":1596344238000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1864-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,20]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["1864"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1864-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,20]]}}}